Abstract

Review Article

Update on the Clinical Applications of Mesenchymal Stem Cells

Khalid Ahmed Al-Anazi*

Published: 21 December, 2023 | Volume 7 - Issue 1 | Pages: 043-064

Mesenchymal stem cells are heterogenous adult multipotent stromal cells that can be isolated from various sources including bone marrow, peripheral blood, umbilical cord blood, dental pulp, and adipose tissue. They have certain regenerative, anti-inflammatory, immunomodulatory, immunosuppressive, antimicrobial, and other properties that enable them to have several therapeutic and clinical applications including treatment of various autoimmune disorders; role in hematopoietic stem cell transplantation and regenerative medicine; treatment of skin, pulmonary and cardiovascular disorders; treatment of neurological and eye diseases; as well as treatment of various infections and their complications. 
Different factors including donor age, biological source, route of administration, and signaling pathways have an impact on the functions and consequently the clinical applications of mesenchymal stromal cells. The products of mesenchymal stem cells such as extracellular vesicles and exosomes reproduce the biological effects and most of the therapeutic actions of the parent stem cells. Genetic engineering and the use of specific mesenchymal stromal cell products have improved their clinical efficacy and decreased their adverse effects. However, despite the recent progress in the use of mesenchymal stem cells, the clinical application of these cells in the treatment of several diseases still faces real challenges that need to be resolved. The current status of mesenchymal stem cells and the controversies related to their clinical utilization in various disease conditions will be thoroughly discussed in this review.

Read Full Article HTML DOI: 10.29328/journal.jsctt.1001034 Cite this Article Read Full Article PDF

Keywords:

Mesenchymal stem cells; Extracellular vesicles; Exosomes; Autoimmune diseases; Hematopoietic stem cell transplantation; Regenerative medicine

References

  1. Auletta JJ, Deans RJ, Bartholomew AM. Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood. 2012 Feb 23;119(8):1801-9. doi: 10.1182/blood-2011-10-384354. Epub 2012 Jan 6. PMID: 22228625; PMCID: PMC3293637.
  2. Al-Anazi KA, Al-Jasser AM. Mesenchymal stem cells-their antimicrobial effects and their promising future role as novel therapies of infectious complications in high-risk patients. In: Progress in stem cell transplantation. Edited by: Demirer T. Intech Open. 2015. doi: 10.5772/60640
  3. Abdal Dayem A, Lee SB, Kim K, Lim KM, Jeon TI, Seok J, Cho AS. Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming. Int J Mol Sci. 2019 Apr 18;20(8):1922. doi: 10.3390/ijms20081922. PMID: 31003536; PMCID: PMC6514654.
  4. Al-Anazi KA, Al-Anazi WK, Al-Jasser AM. Update on COVID-19 infections and the promising role of mesenchymal stem cell therapies in their management. Heighten Science Publications Corporations (HSPI). 2020. doi: 29328/ebook1002
  5. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol. 2006;44(4):215-30. PMID: 17219716.
  6. Kim N, Cho SG. Clinical applications of mesenchymal stem cells. Korean J Intern Med. 2013 Jul;28(4):387-402. doi: 10.3904/kjim.2013.28.4.387. Epub 2013 Jul 1. PMID: 23864795; PMCID: PMC3712145.
  7. Liu TM. Stemness of mesenchymal stem cells. Preliminary study. J Stem Cell Ther Transplant. 2017; 1: 071-073. doi: 10.29328/journal. jsctt.1001008
  8. Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplant. 2016;25(5):829-48. doi: 10.3727/096368915X689622. Epub 2015 Sep 29. PMID: 26423725.
  9. Al-Anazi KA, Bakhit K, Al-Sagheir A, AlHashmi H, Abdulbaqi M, Alshibani Z, Apostolidis I, Estanislo A. Cure of insulin-dependent diabetes mellitus by an autologous hematopoietic stem cell transplantation performed to control multiple myeloma in a patient with chronic renal failure on regular hemodialysis. J Stem Cell Biol Transplant. 2017; 1: 2; 11. doi: 10.21767/ 2575-7725.100011
  10. Nancarrow-Lei R, Mafi P, Mafi R, Khan W. A Systemic Review of Adult Mesenchymal Stem Cell Sources and their Multilineage Differentiation Potential Relevant to Musculoskeletal Tissue Repair and Regeneration. Curr Stem Cell Res Ther. 2017;12(8):601-610. doi: 10.2174/1574888X12666170608124303. PMID: 28595566.
  11. Mafi R, Hindocha S, Mafi P, Griffin M, Khan WS. Sources of adult mesenchymal stem cells applicable for musculoskeletal applications - a systematic review of the literature. Open Orthop J. 2011;5 Suppl 2:242-8. doi: 10.2174/1874325001105010242. Epub 2011 Jul 28. PMID: 21886689; PMCID: PMC3149887.
  12. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011 May 14;9:12. doi: 10.1186/1478-811X-9-12. PMID: 21569606; PMCID: PMC3117820.
  13. Berebichez-Fridman R, Montero-Olvera PR. Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. Sultan Qaboos Univ Med J. 2018 Aug;18(3):e264-e277. doi: 10.18295/squmj.2018.18.03.002. Epub 2018 Dec 19. PMID: 30607265; PMCID: PMC6307657.
  14. Costela-Ruiz VJ, Melguizo-Rodríguez L, Bellotti C, Illescas-Montes R, Stanco D, Arciola CR, Lucarelli E. Different Sources of Mesenchymal Stem Cells for Tissue Regeneration: A Guide to Identifying the Most Favorable One in Orthopedics and Dentistry Applications. Int J Mol Sci. 2022 Jun 6;23(11):6356. doi: 10.3390/ijms23116356. PMID: 35683035; PMCID: PMC9181542.
  15. Klingemann H, Matzilevich D, Marchand J. Mesenchymal Stem Cells - Sources and Clinical Applications. Transfus Med Hemother. 2008;35(4):272-277. doi: 10.1159/000142333. Epub 2008 Jul 21. PMID: 21512642; PMCID: PMC3076359.
  16. Via AG, Frizziero A, Oliva F. Biological properties of mesenchymal Stem Cells from different sources. Muscles Ligaments Tendons J. 2012 Oct 16;2(3):154-62. PMID: 23738292; PMCID: PMC3666517.
  17. Kholodenko IV, Kurbatov LK, Kholodenko RV, Manukyan GV, Yarygin KN. Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope? Cells. 2019 Sep 22;8(10):1127. doi: 10.3390/cells8101127. PMID: 31546729; PMCID: PMC6830330.
  18. Mane S, Taneja S, Madala JS, Agarkhedkar S, Khetan M. Study of Stem Cells in Human Milk. Cureus. 2022 Mar 31;14(3):e23701. doi: 10.7759/cureus.23701. PMID: 35505743; PMCID: PMC9056078.
  19. Nageeb MM, Saadawy SF, Attia SH. Breast milk mesenchymal stem cells abate cisplatin-induced cardiotoxicity in adult male albino rats via modulating the AMPK pathway. Sci Rep. 2022 Oct 20;12(1):17554. doi: 10.1038/s41598-022-22095-2. PMID: 36266413; PMCID: PMC9585145.
  20. Shih YR, Kuo TK, Yang AH, Lee OK, Lee CH. Isolation and characterization of stem cells from the human parathyroid gland. Cell Prolif. 2009 Aug;42(4):461-70. doi: 10.1111/j.1365-2184.2009.00614.x. Epub 2009 May 29. Erratum in: Cell Prolif. 2009 Aug;42(4):569. PMID: 19489980; PMCID: PMC6495903.
  21. Al-Anazi KA, Al-Anazi WK, Al-Jasser AM. The rising role of mesenchymal stem cells in the treatment of various infectious complications. In: Update on Mesenchymal and Induced Pluripotent Stem Cells. 2020. doi:10.5772/intechopen.91475.
  22. Vázquez A, Fernández-Sevilla LM, Jiménez E, Pérez-Cabrera D, Yañez R, Subiza JL, Varas A, Valencia J, Vicente A. Involvement of Mesenchymal Stem Cells in Oral Mucosal Bacterial Immunotherapy. Front Immunol. 2020 Nov 19;11:567391. doi: 10.3389/fimmu.2020.567391. PMID: 33329530; PMCID: PMC7711618.
  23. Di Francesco P, Cajon P, Desterke C, Perron Lepage MF, Lataillade JJ, Kadri T, Lepage OM. Effect of Allogeneic Oral Mucosa Mesenchymal Stromal Cells on Equine Wound Repair. Vet Med Int. 2021 Dec 14;2021:5024905. doi: 10.1155/2021/5024905. PMID: 34950446; PMCID: PMC8692048.
  24. Tu H, Xiao E, Liu O. Taking Microbiota into Consideration in Mesenchymal Stem Cell Research. J Dent Res. 2022 Jul;101(8):880-886. doi: 10.1177/00220345221077986. Epub 2022 Feb 23. PMID: 35196924.
  25. Nery AA, Nascimento IC, Glaser T, Bassaneze V, Krieger JE, Ulrich H. Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications. Cytometry A. 2013 Jan;83(1):48-61. doi: 10.1002/cyto.a.22205. Epub 2012 Oct 1. PMID: 23027703.
  26. Sousa BR, Parreira RC, Fonseca EA, Amaya MJ, Tonelli FM, Lacerda SM, Lalwani P, Santos AK, Gomes KN, Ulrich H, Kihara AH, Resende RR. Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications. Cytometry A. 2014 Jan;85(1):43-77. doi: 10.1002/cyto.a.22402. Epub 2013 Nov 25. PMID: 24700575.
  27. Zhang Z, Yang X, Cao X, Qin A, Zhao J. Current applications of adipose-derived mesenchymal stem cells in bone repair and regeneration: A review of cell experiments, animal models, and clinical trials. Front Bioeng Biotechnol. 2022 Sep 7;10:942128. doi: 10.3389/fbioe.2022.942128. PMID: 36159705; PMCID: PMC9490047.
  28. Corselli M, Crisan M, Murray IR, West CC, Scholes J, Codrea F, Khan N, Péault B. Identification of perivascular mesenchymal stromal/stem cells by flow cytometry. Cytometry A. 2013 Aug;83(8):714-20. doi: 10.1002/cyto.a.22313. Epub 2013 Jul 1. PMID: 23818229.
  29. Ducret M, Farges JC, Pasdeloup M, Perrier-Groult E, Mueller A, Mallein-Gerin F, Fabre H. Phenotypic Identification of Dental Pulp Mesenchymal Stem/Stromal Cells Subpopulations with Multiparametric Flow Cytometry. Methods Mol Biol. 2019;1922:77-90. doi: 10.1007/978-1-4939-9012-2_8. PMID: 30838566.
  30. Liu P, An Y, Zhu T, Tang S, Huang X, Li S, Fu F, Chen J, Xuan K. Mesenchymal stem cells: Emerging concepts and recent advances in their roles in organismal homeostasis and therapy. Front Cell Infect Microbiol. 2023 Mar 9;13:1131218. doi: 10.3389/fcimb.2023.1131218. PMID: 36968100; PMCID: PMC10034133.
  31. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. doi: 10.1080/14653240600855905. PMID: 16923606.
  32. Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, Nolta J, Phinney DG, Sensebe L. Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy. 2019 Oct;21(10):1019-1024. doi: 10.1016/j.jcyt.2019.08.002. Epub 2019 Sep 13. PMID: 31526643.
  33. Fernández Vallone VB, Romaniuk MA, Choi H, Labovsky V, Otaegui J, Chasseing NA. Mesenchymal stem cells and their use in therapy: what has been achieved? Differentiation. 2013 Jan;85(1-2):1-10. doi: 10.1016/j.diff.2012.08.004. Epub 2013 Jan 11. PMID: 23314286.
  34. Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol. 2006 Aug 15;177(4):2080-7. doi: 10.4049/jimmunol.177.4.2080. PMID: 16887966.
  35. Murray IR, Péault B. Q&A: Mesenchymal stem cells - where do they come from and is it important? BMC Biol. 2015 Nov 23;13:99. doi: 10.1186/s12915-015-0212-7. PMID: 26596888; PMCID: PMC4656175.
  36. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 2003 Apr;121(2):368-74. doi: 10.1046/j.1365-2141.2003.04284.x. PMID: 12694261.
  37. Lv FJ, Tuan RS, Cheung KM, Leung VY. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells. 2014 Jun;32(6):1408-19. doi: 10.1002/stem.1681. PMID: 24578244.
  38. Kundrotas G. Surface markers distinguishing mesenchymal stem cells from fibroblasts. Acta Med Lituanica. 2012; 19: 75-79.
  39. Lin CS, Ning H, Lin G, Lue TF. Is CD34 truly a negative marker for mesenchymal stromal cells? Cytotherapy. 2012 Nov;14(10):1159-63. doi: 10.3109/14653249.2012.729817. PMID: 23066784; PMCID: PMC3846603.
  40. Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014 Jun;32(6):1380-9. doi: 10.1002/stem.1661. PMID: 24497003; PMCID: PMC4260088.
  41. Stzepourginski I, Nigro G, Jacob JM, Dulauroy S, Sansonetti PJ, Eberl G, Peduto L. CD34+ mesenchymal cells are a major component of the intestinal stem cells niche at homeostasis and after injury. Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E506-E513. doi: 10.1073/pnas.1620059114. Epub 2017 Jan 10. PMID: 28074039; PMCID: PMC5278455.
  42. Eto H, Ishimine H, Kinoshita K, Watanabe-Susaki K, Kato H, Doi K, Kuno S, Kurisaki A, Yoshimura K. Characterization of human adipose tissue-resident hematopoietic cell populations reveals a novel macrophage subpopulation with CD34 expression and mesenchymal multipotency. Stem Cells Dev. 2013 Mar 15;22(6):985-97. doi: 10.1089/scd.2012.0442. Epub 2012 Dec 21. PMID: 23137270; PMCID: PMC3585481.
  43. Alvarez P, Carrillo E, Vélez C, Hita-Contreras F, Martínez-Amat A, Rodríguez-Serrano F, Boulaiz H, Ortiz R, Melguizo C, Prados J, Aránega A. Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing. Biomed Res Int. 2013;2013:312656. doi: 10.1155/2013/312656. Epub 2013 Jun 17. PMID: 23844360; PMCID: PMC3703413.
  44. Rochefort GY, Delorme B, Lopez A, Hérault O, Bonnet P, Charbord P, Eder V, Domenech J. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells. 2006 Oct;24(10):2202-8. doi: 10.1634/stemcells.2006-0164. Epub 2006 Jun 15. PMID: 16778152.
  45. Lund TC, Tolar J, Orchard PJ. Granulocyte colony-stimulating factor mobilized CFU-F can be found in the peripheral blood but have limited expansion potential. Haematologica. 2008 Jun;93(6):908-12. doi: 10.3324/haematol.12384. Epub 2008 Apr 9. PMID: 18403392.
  46. Gilevich IV, Fedorenko TV, Pashkova IA, Porkhanov VA, Chekhonin VP. Effects of Growth Factors on Mobilization of Mesenchymal Stem Cells. Bull Exp Biol Med. 2017 Mar;162(5):684-686. doi: 10.1007/s10517-017-3687-0. Epub 2017 Mar 31. PMID: 28361423.
  47. Xu L, Li G. Circulating mesenchymal stem cells and their clinical implications. J Orthop Transl. 2014; 2: 1-7. doi: 10.1016/j.jot.2013.11.002.
  48. Koning JJ, Kooij G, de Vries HE, Nolte MA, Mebius RE. Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol. 2013 Mar 4;4:49. doi: 10.3389/fimmu.2013.00049. PMID: 23459632; PMCID: PMC3586765.
  49. Rodríguez-Fuentes DE, Fernández-Garza LE, Samia-Meza JA, Barrera-Barrera SA, Caplan AI, Barrera-Saldaña HA. Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review. Arch Med Res. 2021 Jan;52(1):93-101. doi: 10.1016/j.arcmed.2020.08.006. Epub 2020 Sep 22. PMID: 32977984.
  50. Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017 Jul;74(13):2345-2360. doi: 10.1007/s00018-017-2473-5. Epub 2017 Feb 18. PMID: 28214990.
  51. Wu X, Jiang J, Gu Z, Zhang J, Chen Y, Liu X. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. Stem Cell Res Ther. 2020 Aug 8;11(1):345. doi: 10.1186/s13287-020-01855-9. PMID: 32771052; PMCID: PMC7414268.
  52. Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther. 2016 Aug 31;7(1):125. doi: 10.1186/s13287-016-0363-7. PMID: 27581859; PMCID: PMC5007684.
  53. Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019 Sep;76(17):3323-3348. doi: 10.1007/s00018-019-03125-1. Epub 2019 May 4. PMID: 31055643.
  54. Yang G, Fan X, Liu Y, Jie P, Mazhar M, Liu Y, Dechsupa N, Wang L. Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells. Stem Cell Rev Rep. 2023 Jul;19(5):1214-1231. doi: 10.1007/s12015-023-10539-9. Epub 2023 Apr 14. PMID: 37058201; PMCID: PMC10103048.
  55. Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, Hua D, Shao C, Shi Y. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther. 2022 Mar 21;7(1):92. doi: 10.1038/s41392-022-00932-0. PMID: 35314676; PMCID: PMC8935608.
  56. Zhuang WZ, Lin YH, Su LJ, Wu MS, Jeng HY, Chang HC, Huang YH, Ling TY. Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci. 2021 Apr 14;28(1):28. doi: 10.1186/s12929-021-00725-7. PMID: 33849537; PMCID: PMC8043779.
  57. Liang X, Ding Y, Zhang Y, Tse HF, Lian Q. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2014;23(9):1045-59. doi: 10.3727/096368913X667709. PMID: 23676629.
  58. Müller L, Tunger A, Wobus M, von Bonin M, Towers R, Bornhäuser M, Dazzi F, Wehner R, Schmitz M. Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update. Front Cell Dev Biol. 2021 Feb 9;9:637725. doi: 10.3389/fcell.2021.637725. PMID: 33634139; PMCID: PMC7900158.
  59. Carp DM, Liang Y. Universal or Personalized Mesenchymal Stem Cell Therapies: Impact of Age, Sex, and Biological Source. Cells. 2022 Jun 30;11(13):2077. doi: 10.3390/cells11132077. PMID: 35805161; PMCID: PMC9265811.
  60. Margiana R, Markov A, Zekiy AO, Hamza MU, Al-Dabbagh KA, Al-Zubaidi SH, Hameed NM, Ahmad I, Sivaraman R, Kzar HH, Al-Gazally ME, Mustafa YF, Siahmansouri H. Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review. Stem Cell Res Ther. 2022 Jul 28;13(1):366. doi: 10.1186/s13287-022-03054-0. PMID: 35902958; PMCID: PMC9330677.
  61. Fraile M, Eiro N, Costa LA, Martín A, Vizoso FJ. Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies. Biology (Basel). 2022 Nov 18;11(11):1678. doi: 10.3390/biology11111678. PMID: 36421393; PMCID: PMC9687158.
  62. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 2012 Sep 20;21(14):2724-52. doi: 10.1089/scd.2011.0722. Epub 2012 May 9. PMID: 22468918.
  63. Pontikoglou C, Deschaseaux F, Sensebé L, Papadaki HA. Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev Rep. 2011 Sep;7(3):569-89. doi: 10.1007/s12015-011-9228-8. PMID: 21249477.
  64. Nakao N, Nakayama T, Yahata T, Muguruma Y, Saito S, Miyata Y, Yamamoto K, Naoe T. Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo: advantages over bone marrow-derived mesenchymal stem cells. Am J Pathol. 2010 Aug;177(2):547-54. doi: 10.2353/ajpath.2010.091042. Epub 2010 Jun 17. PMID: 20558580; PMCID: PMC2913350.
  65. Gonzaga VF, Wenceslau CV, Lisboa GS, Frare EO, Kerkis I. Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia. Stem Cells Int. 2017;2017:8076529. doi: 10.1155/2017/8076529. Epub 2017 Dec 3. PMID: 29333168; PMCID: PMC5733198.
  66. Wu J, Zhang W, Ran Q, Xiang Y, Zhong JF, Li SC, Li Z. The Differentiation Balance of Bone Marrow Mesenchymal Stem Cells Is Crucial to Hematopoiesis. Stem Cells Int. 2018 Apr 3;2018:1540148. doi: 10.1155/2018/1540148. PMID: 29765406; PMCID: PMC5903338.
  67. Gao Q, Wang L, Wang S, Huang B, Jing Y, Su J. Bone Marrow Mesenchymal Stromal Cells: Identification, Classification, and Differentiation. Front Cell Dev Biol. 2022 Jan 3;9:787118. doi: 10.3389/fcell.2021.787118. PMID: 35047499; PMCID: PMC8762234.
  68. Laranjeira P, Pedrosa M, Pedreiro S, Gomes J, Martinho A, Antunes B, Ribeiro T, Santos F, Trindade H, Paiva A. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells. Stem Cell Res Ther. 2015 Jan 5;6(1):3. doi: 10.1186/scrt537. PMID: 25559824; PMCID: PMC4417198.
  69. Pedrosa M, Gomes J, Laranjeira P, Duarte C, Pedreiro S, Antunes B, Ribeiro T, Santos F, Martinho A, Fardilha M, Domingues MR, Abecasis M, P da Silva JA, Paiva A. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients. J Tissue Eng Regen Med. 2020 Jan;14(1):16-28. doi: 10.1002/term.2958. Epub 2019 Nov 11. PMID: 31502378.
  70. Zhou X, Cao H, Guo J, Yuan Y, Ni G. Effects of BMSC-Derived EVs on Bone Metabolism. Pharmaceutics. 2022 May 8;14(5):1012. doi: 10.3390/pharmaceutics14051012. PMID: 35631601; PMCID: PMC9146387.
  71. Wang ZG, He ZY, Liang S, Yang Q, Cheng P, Chen AM. Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2020 Nov 27;11(1):511. doi: 10.1186/s13287-020-02032-8. PMID: 33246507; PMCID: PMC7694919.
  72. Bucar S, Branco ADM, Mata MF, Milhano JC, Caramalho Í, Cabral JMS, Fernandes-Platzgummer A, da Silva CL. Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells. Stem Cell Res Ther. 2021 Jul 13;12(1):399. doi: 10.1186/s13287-021-02474-8. PMID: 34256848; PMCID: PMC8278708.
  73. De Toni F, Poglio S, Youcef AB, Cousin B, Pflumio F, Bourin P, Casteilla L, Laharrague P. Human adipose-derived stromal cells efficiently support hematopoiesis in vitro and in vivo: a key step for therapeutic studies. Stem Cells Dev. 2011 Dec;20(12):2127-38. doi: 10.1089/scd.2011.0044. Epub 2011 Apr 13. PMID: 21388235.
  74. Valencia J, Blanco B, Yáñez R, Vázquez M, Herrero Sánchez C, Fernández-García M, Rodríguez Serrano C, Pescador D, Blanco JF, Hernando-Rodríguez M, Sánchez-Guijo F, Lamana ML, Segovia JC, Vicente Á, Del Cañizo C, Zapata AG. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor. Cytotherapy. 2016 Oct;18(10):1297-311. doi: 10.1016/j.jcyt.2016.07.006. PMID: 27637760.
  75. Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med. 2013 Jun;2(6):455-63. doi: 10.5966/sctm.2012-0184. Epub 2013 May 21. PMID: 23694810; PMCID: PMC3673757.
  76. Yousefifard M, Nasirinezhad F, Shardi Manaheji H, Janzadeh A, Hosseini M, Keshavarz M. Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther. 2016 Mar 8;7:36. doi: 10.1186/s13287-016-0295-2. PMID: 26957122; PMCID: PMC4784350.
  77. Takahashi A, Nakajima H, Uchida K, Takeura N, Honjoh K, Watanabe S, Kitade M, Kokubo Y, Johnson WEB, Matsumine A. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury. Cell Transplant. 2018 Jul;27(7):1126-1139. doi: 10.1177/0963689718780309. Epub 2018 Jun 27. PMID: 29947256; PMCID: PMC6158550.
  78. Lombardi F, Palumbo P, Augello FR, Cifone MG, Cinque B, Giuliani M. Secretome of Adipose Tissue-Derived Stem Cells (ASCs) as a Novel Trend in Chronic Non-Healing Wounds: An Overview of Experimental In Vitro and In Vivo Studies and Methodological Variables. Int J Mol Sci. 2019 Jul 30;20(15):3721. doi: 10.3390/ijms20153721. PMID: 31366040; PMCID: PMC6696601.
  79. Guo J, Hu H, Gorecka J, Bai H, He H, Assi R, Isaji T, Wang T, Setia O, Lopes L, Gu Y, Dardik A. Adipose-derived mesenchymal stem cells accelerate diabetic wound healing in a similar fashion as bone marrow-derived cells. Am J Physiol Cell Physiol. 2018 Dec 1;315(6):C885-C896. doi: 10.1152/ajpcell.00120.2018. Epub 2018 Nov 7. PMID: 30404559; PMCID: PMC6336941.
  80. Pomatto M, Gai C, Negro F, Cedrino M, Grange C, Ceccotti E, Togliatto G, Collino F, Tapparo M, Figliolini F, Lopatina T, Brizzi MF, Camussi G. Differential Therapeutic Effect of Extracellular Vesicles Derived by Bone Marrow and Adipose Mesenchymal Stem Cells on Wound Healing of Diabetic Ulcers and Correlation to Their Cargoes. Int J Mol Sci. 2021 Apr 8;22(8):3851. doi: 10.3390/ijms22083851. PMID: 33917759; PMCID: PMC8068154.
  81. Maguire G. The Safe and Efficacious Use of Secretome From Fibroblasts and Adipose-derived (but not Bone Marrow-derived) Mesenchymal Stem Cells for Skin Therapeutics. J Clin Aesthet Dermatol. 2019 Aug;12(8):E57-E69. Epub 2019 Aug 1. PMID: 31531174; PMCID: PMC6715117.
  82. Ajit A, Ambika Gopalankutty I. Adipose-derived stem cell secretome as a cell-free product for cutaneous wound healing. 3 Biotech. 2021 Sep;11(9):413. doi: 10.1007/s13205-021-02958-7. Epub 2021 Aug 16. PMID: 34476171; PMCID: PMC8368523.
  83. Sheykhhasan M, Wong JKL, Seifalian AM. Human Adipose-Derived Stem Cells with Great Therapeutic Potential. Curr Stem Cell Res Ther. 2019;14(7):532-548. doi: 10.2174/1574888X14666190411121528. PMID: 30973112.
  84. Mazini L, Ezzoubi M, Malka G. Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19. Stem Cell Res Ther. 2021 Jan 4;12(1):1. doi: 10.1186/s13287-020-02006-w. PMID: 33397467; PMCID: PMC7781178.
  85. Frese L, Dijkman PE, Hoerstrup SP. Adipose Tissue-Derived Stem Cells in Regenerative Medicine. Transfus Med Hemother. 2016 Jul;43(4):268-274. doi: 10.1159/000448180. Epub 2016 Jul 26. PMID: 27721702; PMCID: PMC5040903.
  86. Bunnell BA. Adipose Tissue-Derived Mesenchymal Stem Cells. Cells. 2021 Dec 6;10(12):3433. doi: 10.3390/cells10123433. PMID: 34943941; PMCID: PMC8700397.
  87. El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev. 2014 Oct;20(5):523-44. doi: 10.1089/ten.TEB.2013.0664. Epub 2014 Apr 22. PMID: 24552279.
  88. Watson N, Divers R, Kedar R, Mehindru A, Mehindru A, Borlongan MC, Borlongan CV. Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells. Cytotherapy. 2015 Jan;17(1):18-24. doi: 10.1016/j.jcyt.2014.08.009. Epub 2014 Oct 18. PMID: 25442786; PMCID: PMC4274214.
  89. Abbaszadeh H, Ghorbani F, Derakhshani M, Movassaghpour AA, Yousefi M, Talebi M, Shamsasenjan K. Regenerative potential of Wharton's jelly-derived mesenchymal stem cells: A new horizon of stem cell therapy. J Cell Physiol. 2020 Dec;235(12):9230-9240. doi: 10.1002/jcp.29810. Epub 2020 Jun 18. PMID: 32557631.
  90. Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med. 2014 Sep;34(3):695-704. doi: 10.3892/ijmm.2014.1821. Epub 2014 Jun 25. PMID: 24970492; PMCID: PMC4121354.
  91. Nagamura-Inoue T, He H. Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World J Stem Cells. 2014 Apr 26;6(2):195-202. doi: 10.4252/wjsc.v6.i2.195. PMID: 24772246; PMCID: PMC3999777.
  92. Shang Y, Guan H, Zhou F. Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders. Front Cell Dev Biol. 2021 May 3;9:570179. doi: 10.3389/fcell.2021.570179. PMID: 34012958; PMCID: PMC8126649.
  93. Chen Y, Shen H, Ding Y, Yu Y, Shao L, Shen Z. The application of umbilical cord-derived MSCs in cardiovascular diseases. J Cell Mol Med. 2021 Sep;25(17):8103-8114. doi: 10.1111/jcmm.16830. Epub 2021 Aug 11. PMID: 34378345; PMCID: PMC8419197.
  94. Karnas E, Dudek P, Zuba-Surma EK. Stem cell- derived extracellular vesicles as new tools in regenerative medicine - Immunomodulatory role and future perspectives. Front Immunol. 2023 Jan 24;14:1120175. doi: 10.3389/fimmu.2023.1120175. PMID: 36761725; PMCID: PMC9902918.
  95. Campanella C, Caruso Bavisotto C, Logozzi M, Marino Gammazza A, Mizzoni D, Cappello F, Fais S. On the Choice of the Extracellular Vesicles for Therapeutic Purposes. Int J Mol Sci. 2019 Jan 9;20(2):236. doi: 10.3390/ijms20020236. PMID: 30634425; PMCID: PMC6359369.
  96. Yin L, Liu X, Shi Y, Ocansey DKW, Hu Y, Li X, Zhang C, Xu W, Qian H. Therapeutic Advances of Stem Cell-Derived Extracellular Vesicles in Regenerative Medicine. Cells. 2020 Mar 13;9(3):707. doi: 10.3390/cells9030707. PMID: 32183102; PMCID: PMC7140663.
  97. Bruno S, Chiabotto G, Favaro E, Deregibus MC, Camussi G. Role of extracellular vesicles in stem cell biology. Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C303-C313. doi: 10.1152/ajpcell.00129.2019. Epub 2019 May 15. PMID: 31091143; PMCID: PMC6732418.
  98. Zhang B, Yeo RW, Tan KH, Lim SK. Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles. Int J Mol Sci. 2016 Feb 6;17(2):174. doi: 10.3390/ijms17020174. PMID: 26861305; PMCID: PMC4783908.
  99. Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, Guo L, Zhang X, Zhou X, Xu X, Yan X, Wang Y, Zhang J, Xu A, Tse HF, Lian Q. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis. 2022 Jul 4;13(7):580. doi: 10.1038/s41419-022-05034-x. PMID: 35787632; PMCID: PMC9252569.
  100. Tsiapalis D, O'Driscoll L. Mesenchymal Stem Cell Derived Extracellular Vesicles for Tissue Engineering and Regenerative Medicine Applications. Cells. 2020 Apr 16;9(4):991. doi: 10.3390/cells9040991. PMID: 32316248; PMCID: PMC7226943.
  101. Fiore EJ, Domínguez LM, Bayo J, García MG, Mazzolini GD. Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: Cells and extracellular vesicles as therapeutic strategies. World J Gastroenterol. 2018 Jun 21;24(23):2427-2440. doi: 10.3748/wjg.v24.i23.2427. PMID: 29930465; PMCID: PMC6010941.
  102. Racchetti G, Meldolesi J. Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success. Biomedicines. 2021 Jun 10;9(6):667. doi: 10.3390/biomedicines9060667. PMID: 34200818; PMCID: PMC8230522.
  103. Kahmini FR, Shahgaldi S. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders. Exp Mol Pathol. 2021 Feb;118:104566. doi: 10.1016/j.yexmp.2020.104566. Epub 2020 Nov 6. PMID: 33160961.
  104. Matheakakis A, Batsali A, Papadaki HA, Pontikoglou CG. Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications. Int J Mol Sci. 2021 Sep 20;22(18):10132. doi: 10.3390/ijms221810132. PMID: 34576296; PMCID: PMC8468750.
  105. Zheng G, Huang R, Qiu G, Ge M, Wang J, Shu Q, Xu J. Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis. Cell Tissue Res. 2018 Oct;374(1):1-15. doi: 10.1007/s00441-018-2871-5. Epub 2018 Jun 28. PMID: 29955951.
  106. Weng Z, Zhang B, Wu C, Yu F, Han B, Li B, Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol. 2021 Sep 3;14(1):136. doi: 10.1186/s13045-021-01141-y. PMID: 34479611; PMCID: PMC8414028.
  107. Cheng Y, Cao X, Qin L. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy for Sepsis. Front Immunol. 2020 Apr 21;11:647. doi: 10.3389/fimmu.2020.00647. PMID: 32373121; PMCID: PMC7186296.
  108. Williams T, Salmanian G, Burns M, Maldonado V, Smith E, Porter RM, Song YH, Samsonraj RM. Versatility of mesenchymal stem cell-derived extracellular vesicles in tissue repair and regenerative applications. Biochimie. 2023 Apr;207:33-48. doi: 10.1016/j.biochi.2022.11.011. Epub 2022 Nov 23. PMID: 36427681.
  109. Gowen A, Shahjin F, Chand S, Odegaard KE, Yelamanchili SV. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications. Front Cell Dev Biol. 2020 Mar 12;8:149. doi: 10.3389/fcell.2020.00149. PMID: 32226787; PMCID: PMC7080981.
  110. Wiest EF, Zubair AC. Challenges of manufacturing mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine. Cytotherapy. 2020 Nov;22(11):606-612. doi: 10.1016/j.jcyt.2020.04.040. Epub 2020 Jun 10. PMID: 32532592.
  111. Fuloria S, Subramaniyan V, Dahiya R, Dahiya S, Sudhakar K, Kumari U, Sathasivam K, Meenakshi DU, Wu YS, Sekar M, Malviya R, Singh A, Fuloria NK. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Regenerative Potential and Challenges. Biology (Basel). 2021 Feb 25;10(3):172. doi: 10.3390/biology10030172. PMID: 33668707; PMCID: PMC7996168.
  112. Fujita Y, Kadota T, Araya J, Ochiya T, Kuwano K. Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases. J Clin Med. 2018 Oct 14;7(10):355. doi: 10.3390/jcm7100355. PMID: 30322213; PMCID: PMC6210470.
  113. Maumus M, Rozier P, Boulestreau J, Jorgensen C, Noël D. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation. Front Bioeng Biotechnol. 2020 Sep 10;8:997. doi: 10.3389/fbioe.2020.00997. PMID: 33015001; PMCID: PMC7511661.
  114. Allan D, Tieu A, Lalu M, Burger D. Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application. Stem Cells Transl Med. 2020 Jan;9(1):39-46. doi: 10.1002/sctm.19-0114. Epub 2019 Aug 14. PMID: 31411820; PMCID: PMC6954691.
  115. Rani S, Ryan AE, Griffin MD, Ritter T. Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. Mol Ther. 2015 May;23(5):812-823. doi: 10.1038/mt.2015.44. Epub 2015 Mar 19. PMID: 25868399; PMCID: PMC4427881.
  116. Chua JKE, Lim J, Foong LH, Mok CY, Tan HY, Tung XY, Ramasamy TS, Govindasamy V, Then KY, Das AK, Cheong SK. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Progress and Remaining Hurdles in Developing Regulatory Compliant Quality Control Assays. Adv Exp Med Biol. 2022;1401:191-211. doi: 10.1007/5584_2022_728. PMID: 35816249.
  117. Sun Y, Liu G, Zhang K, Cao Q, Liu T, Li J. Mesenchymal stem cells-derived exosomes for drug delivery. Stem Cell Res Ther. 2021 Oct 30;12(1):561. doi: 10.1186/s13287-021-02629-7. PMID: 34717769; PMCID: PMC8557580.
  118. Lotfy A, AboQuella NM, Wang H. Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther. 2023 Apr 7;14(1):66. doi: 10.1186/s13287-023-03287-7. PMID: 37024925; PMCID: PMC10079493.
  119. Oveili E, Vafaei S, Bazavar H, Eslami Y, Mamaghanizadeh E, Yasamineh S, Gholizadeh O. The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases. Cell Commun Signal. 2023 Jan 23;21(1):20. doi: 10.1186/s12964-022-01017-9. PMID: 36690996; PMCID: PMC9869323.
  120. Liu WZ, Ma ZJ, Li JR, Kang XW. Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury. Stem Cell Res Ther. 2021 Feb 3;12(1):102. doi: 10.1186/s13287-021-02153-8. PMID: 33536064; PMCID: PMC7860030.
  121. Bhaskar B, Mekala NK, Baadhe RR, Rao PS. Role of signaling pathways in mesenchymal stem cell differentiation. Curr Stem Cell Res Ther. 2014;9(6):508-12. doi: 10.2174/1574888x09666140812112002. PMID: 25116449.
  122. Samakova A, Gazova A, Sabova N, Valaskova S, Jurikova M, Kyselovic J. The PI3k/Akt pathway is associated with angiogenesis, oxidative stress and survival of mesenchymal stem cells in pathophysiologic condition in ischemia. Physiol Res. 2019 Nov 30;68(Suppl 2):S131-S138. doi: 10.33549/physiolres.934345. PMID: 31842576.
  123. Chen J, Crawford R, Chen C, Xiao Y. The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration. Tissue Eng Part B Rev. 2013 Dec;19(6):516-28. doi: 10.1089/ten.TEB.2012.0672. Epub 2013 Jul 10. PMID: 23651329.
  124. Takam Kamga P, Bazzoni R, Dal Collo G, Cassaro A, Tanasi I, Russignan A, Tecchio C, Krampera M. The Role of Notch and Wnt Signaling in MSC Communication in Normal and Leukemic Bone Marrow Niche. Front Cell Dev Biol. 2021 Jan 8;8:599276. doi: 10.3389/fcell.2020.599276. PMID: 33490067; PMCID: PMC7820188.
  125. Li Y, Jin D, Xie W, Wen L, Chen W, Xu J, Ding J, Ren D. PPAR-γ and Wnt Regulate the Differentiation of MSCs into Adipocytes and Osteoblasts Respectively. Curr Stem Cell Res Ther. 2018 Feb 23;13(3):185-192. doi: 10.2174/1574888X12666171012141908. PMID: 29034841.
  126. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008 Jul 15;112(2):295-307. doi: 10.1182/blood-2007-07-103697. Epub 2008 Mar 10. PMID: 18332228.
  127. Kobolak J, Dinnyes A, Memic A, Khademhosseini A, Mobasheri A. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods. 2016 Apr 15;99:62-8. doi: 10.1016/j.ymeth.2015.09.016. Epub 2015 Sep 15. PMID: 26384580.
  128. Berebichez-Fridman R, Montero-Olvera PR. Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. Sultan Qaboos Univ Med J. 2018 Aug;18(3):e264-e277. doi: 10.18295/squmj.2018.18.03.002. Epub 2018 Dec 19. PMID: 30607265; PMCID: PMC6307657.
  129. Wang S, Qu X, Zhao RC. Clinical applications of mesenchymal stem cells. J Hematol Oncol. 2012 Apr 30;5:19. doi: 10.1186/1756-8722-5-19. PMID: 22546280; PMCID: PMC3416655.
  130. Zhou T, Yuan Z, Weng J, Pei D, Du X, He C, Lai P. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021 Feb 12;14(1):24. doi: 10.1186/s13045-021-01037-x. PMID: 33579329; PMCID: PMC7880217.
  131. Wu J, Chen LH, Sun SY, Li Y, Ran XW. Mesenchymal stem cell-derived exosomes: The dawn of diabetic wound healing. World J Diabetes. 2022 Dec 15;13(12):1066-1095. doi: 10.4239/wjd.v13.i12.1066. PMID: 36578867; PMCID: PMC9791572.
  132. Hu JC, Zheng CX, Sui BD, Liu WJ, Jin Y. Mesenchymal stem cell-derived exosomes: A novel and potential remedy for cutaneous wound healing and regeneration. World J Stem Cells. 2022 May 26;14(5):318-329. doi: 10.4252/wjsc.v14.i5.318. PMID: 35722196; PMCID: PMC9157601.
  133. Wright A, Arthaud-Day ML, Weiss ML. Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species. Front Cell Dev Biol. 2021 Feb 16;9:632717. doi: 10.3389/fcell.2021.632717. PMID: 33665190; PMCID: PMC7921162.
  134. Gorman E, Millar J, McAuley D, O'Kane C. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential. Expert Rev Respir Med. 2021 Mar;15(3):301-324. doi: 10.1080/17476348.2021.1848555. Epub 2020 Nov 26. PMID: 33172313.
  135. Mattoli S, Schmidt M. Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives. Adv Ther. 2023 Jun;40(6):2626-2692. doi: 10.1007/s12325-023-02507-z. Epub 2023 Apr 17. PMID: 37069355; PMCID: PMC10109238.
  136. Yao W, Shi L, Zhang Y, Dong H, Zhang Y. Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives. Stem Cell Res Ther. 2022 Mar 24;13(1):124. doi: 10.1186/s13287-022-02810-6. PMID: 35321737; PMCID: PMC8942612.
  137. Ringdén O, Moll G, Gustafsson B, Sadeghi B. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome. Front Immunol. 2022 Mar 18;13:839844. doi: 10.3389/fimmu.2022.839844. PMID: 35371003; PMCID: PMC8973075.
  138. Khandelwal V, Sharma T, Gupta S, Singh S, Sharma MK, Parashar D, Kashyap VK. Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2. Mol Biol Rep. 2023 Mar;50(3):2663-2683. doi: 10.1007/s11033-022-07957-2. Epub 2022 Dec 19. PMID: 36536185; PMCID: PMC9762873.
  139. Nandina RQ, Eriani K, Asrizal CW, Azhar A. Mesenchymal stem cell as a successful therapy for COVID-19 patient: Systematic review. Biosaintifika: J Biol Biol Edu. 2022; 14 (1): 36-47. doi: 10.15294/biosaintifika.v14i1.32367
  140. Liu P, An Y, Zhu T, Tang S, Huang X, Li S, Fu F, Chen J, Xuan K. Mesenchymal stem cells: Emerging concepts and recent advances in their roles in organismal homeostasis and therapy. Front Cell Infect Microbiol. 2023 Mar 9;13:1131218. doi: 10.3389/fcimb.2023.1131218. PMID: 36968100; PMCID: PMC10034133.
  141. Jasim SA, Yumashev AV, Abdelbasset WK, Margiana R, Markov A, Suksatan W, Pineda B, Thangavelu L, Ahmadi SH. Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases. Stem Cell Res Ther. 2022 Mar 7;13(1):101. doi: 10.1186/s13287-022-02782-7. PMID: 35255979; PMCID: PMC8900359.
  142. Chen Y, Yu Q, Hu Y, Shi Y. Current Research and Use of Mesenchymal Stem Cells in the Therapy of Autoimmune Diseases. Curr Stem Cell Res Ther. 2019;14(7):579-582. doi: 10.2174/1574888X14666190429141421. PMID: 31729289.
  143. Figueroa FE, Carrión F, Villanueva S, Khoury M. Mesenchymal stem cell treatment for autoimmune diseases: a critical review. Biol Res. 2012;45(3):269-77. doi: 10.4067/S0716-97602012000300008. PMID: 23283436.
  144. Huldani H, Abdalkareem Jasim S, Olegovich Bokov D, Abdelbasset WK, Nader Shalaby M, Thangavelu L, Margiana R, Qasim MT. Application of extracellular vesicles derived from mesenchymal stem cells as potential therapeutic tools in autoimmune and rheumatic diseases. Int Immunopharmacol. 2022 May;106:108634. doi: 10.1016/j.intimp.2022.108634. Epub 2022 Feb 19. PMID: 35193053.
  145. Wu Q, Zheng S, Qin Y, Zheng X, Chen H, Yang T, Zhang M. Efficacy and safety of stem cells transplantation in patients with type 1 diabetes mellitus-a systematic review and meta-analysis. Endocr J. 2020 Aug 28;67(8):827-840. doi: 10.1507/endocrj.EJ20-0050. Epub 2020 May 23. PMID: 32321876.
  146. He J, Kong D, Yang Z, Guo R, Amponsah AE, Feng B, Zhang X, Zhang W, Liu A, Ma J, O'Brien T, Cui H. Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data. PLoS One. 2021 Mar 11;16(3):e0247662. doi: 10.1371/journal.pone.0247662. PMID: 33705413; PMCID: PMC7951834.
  147. Zeng L, Yu G, Yang K, Xiang W, Li J, Chen H. Efficacy and Safety of Mesenchymal Stem Cell Transplantation in the Treatment of Autoimmune Diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Multiple Sclerosis, and Ankylosing Spondylitis): A Systematic Review and Meta-Analysis of Randomized Controlled Trial. Stem Cells Int. 2022 Mar 24;2022:9463314. doi: 10.1155/2022/9463314. PMID: 35371265; PMCID: PMC8970953.
  148. Liu S, Guo YL, Yang JY, Wang W, Xu J. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis]. Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Dec 18;50(6):1014-1021. Chinese. PMID: 30562774.
  149. Cui J, Jin L, Ding M, He J, Yang L, Cui S, Wang X, Ma J, Liu A. Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis. Stem Cell Res Ther. 2022 Mar 21;13(1):118. doi: 10.1186/s13287-022-02786-3. PMID: 35313985; PMCID: PMC8935249.
  150. Oliveira AG, Gonçalves M, Ferreira H, M Neves N. Growing evidence supporting the use of mesenchymal stem cell therapies in multiple sclerosis: A systematic review. Mult Scler Relat Disord. 2020 Feb;38:101860. doi: 10.1016/j.msard.2019.101860. Epub 2019 Nov 18. PMID: 31765999.
  151. Sarvar DP, Effatpanah H, Akbarzadehlaleh P, Shamsasenjan K. Mesenchymal stromal cell-derived extracellular vesicles: novel approach in hematopoietic stem cell transplantation. Stem Cell Res Ther. 2022 May 16;13(1):202. doi: 10.1186/s13287-022-02875-3. PMID: 35578300; PMCID: PMC9109321.
  152. De Luca L, Trino S, Laurenzana I, Lamorte D, Caivano A, Del Vecchio L, Musto P. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation? Int J Mol Sci. 2017 May 9;18(5):1022. doi: 10.3390/ijms18051022. PMID: 28486431; PMCID: PMC5454935.
  153. Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009;11(5):503-15. doi: 10.1080/14653240903193806. PMID: 19728189; PMCID: PMC2766085.
  154. Kim EJ, Kim N, Cho SG. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Exp Mol Med. 2013 Jan 10;45(1):e2. doi: 10.1038/emm.2013.2. PMID: 23306700; PMCID: PMC3584660.
  155. Burnham AJ, Daley-Bauer LP, Horwitz EM. Mesenchymal stromal cells in hematopoietic cell transplantation. Blood Adv. 2020 Nov 24;4(22):5877-5887. doi: 10.1182/bloodadvances.2020002646. PMID: 33232479; PMCID: PMC7686890.
  156. Wu KH, Wu HP, Chan CK, Hwang SM, Peng CT, Chao YH. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides. Cell Transplant. 2013;22(4):723-9. doi: 10.3727/096368912X655217. Epub 2012 Oct 12. PMID: 23068433.
  157. Chen X, Wang C, Yin J, Xu J, Wei J, Zhang Y. Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. PLoS One. 2015 Aug 31;10(8):e0136991. doi: 10.1371/journal.pone.0136991. PMID: 26323092; PMCID: PMC4554731.
  158. Morata-Tarifa C, Macías-Sánchez MDM, Gutiérrez-Pizarraya A, Sanchez-Pernaute R. Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis. Stem Cell Res Ther. 2020 Feb 18;11(1):64. doi: 10.1186/s13287-020-01592-z. PMID: 32070420; PMCID: PMC7027118.
  159. Hashmi S, Ahmed M, Murad MH, Litzow MR, Adams RH, Ball LM, Prasad VK, Kebriaei P, Ringden O. Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis. Lancet Haematol. 2016 Jan;3(1):e45-52. doi: 10.1016/S2352-3026(15)00224-0. Epub 2015 Nov 27. PMID: 26765648.
  160. Li R, Tu J, Zhao J, Pan H, Fang L, Shi J. Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?-a systematic review and meta-analysis. Stem Cell Res Ther. 2021 Feb 4;12(1):106. doi: 10.1186/s13287-021-02170-7. PMID: 33541414; PMCID: PMC7860635.
  161. Munneke JM, Spruit MJ, Cornelissen AS, van Hoeven V, Voermans C, Hazenberg MD. The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature. Transplantation. 2016 Nov;100(11):2309-2314. doi: 10.1097/TP.0000000000001029. PMID: 26714122.
  162. Chen X, Wang F, Huang Z, Wu Y, Geng J, Wang Y. Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: An Update and Concise Review. Int J Med Sci. 2021 Jun 1;18(13):2849-2870. doi: 10.7150/ijms.59218. PMID: 34220313; PMCID: PMC8241779.
  163. Antoniou KM, Karagiannis K, Tsitoura E, Bibaki E, Lasithiotaki I, Proklou A, Spandidos DA, Tzanakis N. Clinical applications of mesenchymal stem cells in chronic lung diseases. Biomed Rep. 2018 Apr;8(4):314-318. doi: 10.3892/br.2018.1067. Epub 2018 Feb 16. PMID: 29556380; PMCID: PMC5844081.
  164. Le Thi Bich P, Nguyen Thi H, Dang Ngo Chau H, Phan Van T, Do Q, Dong Khac H, Le Van D, Nguyen Huy L, Mai Cong K, Ta Ba T, Do Minh T, Vu Bich N, Truong Chau N, Van Pham P. Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study. Stem Cell Res Ther. 2020 Feb 13;11(1):60. doi: 10.1186/s13287-020-1583-4. PMID: 32054512; PMCID: PMC7020576.
  165. Caretti A, Peli V, Colombo M, Zulueta A. Lights and Shadows in the Use of Mesenchymal Stem Cells in Lung Inflammation, a Poorly Investigated Topic in Cystic Fibrosis. Cells. 2019 Dec 19;9(1):20. doi: 10.3390/cells9010020. PMID: 31861724; PMCID: PMC7016730.
  166. Monsel A, Zhu YG, Gudapati V, Lim H, Lee JW. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther. 2016 Jul;16(7):859-71. doi: 10.1517/14712598.2016.1170804. Epub 2016 Apr 12. PMID: 27011289; PMCID: PMC5280876.
  167. Li X, Yue S, Luo Z. Mesenchymal stem cells in idiopathic pulmonary fibrosis. Oncotarget. 2017 May 23;8(60):102600-102616. doi: 10.18632/oncotarget.18126. PMID: 29254275; PMCID: PMC5731985.
  168. Yao Y, Zheng Z, Song Q. Mesenchymal stem cells: A double-edged sword in radiation-induced lung injury. Thorac Cancer. 2018 Feb;9(2):208-217. doi: 10.1111/1759-7714.12573. Epub 2017 Dec 13. PMID: 29235254; PMCID: PMC5792737.
  169. Zanoni M, Cortesi M, Zamagni A, Tesei A. The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis. Int J Mol Sci. 2019 Aug 8;20(16):3876. doi: 10.3390/ijms20163876. PMID: 31398940; PMCID: PMC6719901.
  170. Guo Y, Yu Y, Hu S, Chen Y, Shen Z. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis. 2020 May 11;11(5):349. doi: 10.1038/s41419-020-2542-9. PMID: 32393744; PMCID: PMC7214402.
  171. Gubert F, da Silva JS, Vasques JF, de Jesus Gonçalves RG, Martins RS, de Sá MPL, Mendez-Otero R, Zapata-Sudo G. Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases. Int J Mol Sci. 2021 Jul 12;22(14):7447. doi: 10.3390/ijms22147447. PMID: 34299066; PMCID: PMC8307175.
  172. Wang Y, Qi Z, Yan Z, Ji N, Yang X, Gao D, Hu L, Lv H, Zhang J, Li M. Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease. Front Cell Dev Biol. 2022 Jan 12;9:742088. doi: 10.3389/fcell.2021.742088. PMID: 35096808; PMCID: PMC8790228.
  173. Poomani MS, Mariappan I, Perumal R, Regurajan R, Muthan K, Subramanian V. Mesenchymal Stem Cell (MSCs) Therapy for Ischemic Heart Disease: A Promising Frontier. Glob Heart. 2022 Mar 3;17(1):19. doi: 10.5334/gh.1098. PMID: 35342702; PMCID: PMC8916054.
  174. Lalu MM, Mazzarello S, Zlepnig J, Dong YYR, Montroy J, McIntyre L, Devereaux PJ, Stewart DJ, David Mazer C, Barron CC, McIsaac DI, Fergusson DA. Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis. Stem Cells Transl Med. 2018 Dec;7(12):857-866. doi: 10.1002/sctm.18-0120. Epub 2018 Sep 26. PMID: 30255989; PMCID: PMC6265630.
  175. Fan M, Huang Y, Chen Z, Xia Y, Chen A, Lu D, Wu Y, Zhang N, Qian J. Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis. Stem Cell Res Ther. 2019 May 31;10(1):150. doi: 10.1186/s13287-019-1258-1. Erratum in: Stem Cell Res Ther. 2019 Jul 15;10(1):206. PMID: 31151406; PMCID: PMC6544951.
  176. Shen T, Xia L, Dong W, Wang J, Su F, Niu S, Wang Q, Fang Y. A Systematic Review and Meta-Analysis: Safety and Efficacy of Mesenchymal Stem Cells Therapy for Heart Failure. Curr Stem Cell Res Ther. 2021;16(3):354-365. doi: 10.2174/1574888X15999200820171432. PMID: 32867655.
  177. Yu J, Zhang RF, Mao YL, Zhang H. Efficacy and Safety of Mesenchymal Stem Cell Therapy in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Curr Stem Cell Res Ther. 2022;17(8):793-807. doi: 10.2174/1574888X16666210816111031. PMID: 34397334.
  178. Soares MBP, Gonçalves RGJ, Vasques JF, da Silva-Junior AJ, Gubert F, Santos GC, de Santana TA, Almeida Sampaio GL, Silva DN, Dominici M, Mendez-Otero R. Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases. Front Mol Neurosci. 2022 Jun 16; 15:883378. doi: 10.3389/fnmol.2022.883378. PMID: 35782379; PMCID: PMC9244712.
  179. Andrzejewska A, Dabrowska S, Lukomska B, Janowski M. Mesenchymal Stem Cells for Neurological Disorders. Adv Sci (Weinh). 2021 Feb 24;8(7):2002944. doi: 10.1002/advs.202002944. PMID: 33854883; PMCID: PMC8024997.
  180. Zhang ZX, Zhou YJ, Gu P, Zhao W, Chen HX, Wu RY, Zhou LY, Cui QZ, Sun SK, Zhang LQ, Zhang K, Xu HJ, Chai XQ, An SJ. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson's disease and neuronal damage through inhibition of microglia. Neural Regen Res. 2023 Oct;18(10):2291-2300. doi: 10.4103/1673-5374.368300. PMID: 37056150; PMCID: PMC10328268.
  181. Heris RM, Shirvaliloo M, Abbaspour-Aghdam S, Hazrati A, Shariati A, Youshanlouei HR, Niaragh FJ, Valizadeh H, Ahmadi M. The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment. Stem Cell Res Ther. 2022 Jul 28;13(1):371. doi: 10.1186/s13287-022-03050-4. PMID: 35902981; PMCID: PMC9331055.
  182. Kitada M, Dezawa M. Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy. Parkinsons Dis. 2012; 2012:873706. doi: 10.1155/2012/873706. Epub 2012 Feb 28. PMID: 22530164; PMCID: PMC3317001.
  183. Venkatesh K, Sen D. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease. Curr Stem Cell Res Ther. 2017;12(4):326-347. doi: 10.2174/1574888X12666161114122059. PMID: 27842480.
  184. Chen HX, Liang FC, Gu P, Xu BL, Xu HJ, Wang WT, Hou JY, Xie DX, Chai XQ, An SJ. Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy. Cell Death Dis. 2020 Apr 27;11(4):288. doi: 10.1038/s41419-020-2473-5. PMID: 32341347; PMCID: PMC7184757.
  185. Holan V, Palacka K, Hermankova B. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials. Cells. 2021 Mar 7;10(3):588. doi: 10.3390/cells10030588. PMID: 33799995; PMCID: PMC8001847.
  186. Mannino G, Russo C, Longo A, Anfuso CD, Lupo G, Lo Furno D, Giuffrida R, Giurdanella G. Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases. World J Stem Cells. 2021 Jun 26;13(6):632-644. doi: 10.4252/wjsc.v13.i6.632. PMID: 34249232; PMCID: PMC8246249.
  187. Adak S, Magdalene D, Deshmukh S, Das D, Jaganathan BG. A Review on Mesenchymal Stem Cells for Treatment of Retinal Diseases. Stem Cell Rev Rep. 2021 Aug;17(4):1154-1173. doi: 10.1007/s12015-020-10090-x. Epub 2021 Jan 6. PMID: 33410097; PMCID: PMC7787584.
  188. Chen X, Jiang Y, Duan Y, Zhang X, Li X. Mesenchymal-Stem-Cell-Based Strategies for Retinal Diseases. Genes (Basel). 2022 Oct 19;13(10):1901. doi: 10.3390/genes13101901. PMID: 36292786; PMCID: PMC9602395.
  189. Yudintceva N, Mikhailova N, Fedorov V, Samochernych K, Vinogradova T, Muraviov A, Shevtsov M. Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice. Bioengineering (Basel). 2022 Nov 8;9(11):662. doi: 10.3390/bioengineering9110662. PMID: 36354573; PMCID: PMC9687734.
  190. Shaw TD, Krasnodembskaya AD, Schroeder GN, Zumla A, Maeurer M, O'Kane CM. Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases. Clin Microbiol Rev. 2021 Dec 15;34(4):e0006421. doi: 10.1128/CMR.00064-21. Epub 2021 Oct 6. PMID: 34612662; PMCID: PMC8510528.
  191. Battah B. Mesenchymal stem cells: Potential role against bacterial infection. J Biosci Med. 2022; 10 (3): 97-113. doi:4236/jbm.2022.103011
  192. Laroye C, Gibot S, Reppel L, Bensoussan D. Concise Review: Mesenchymal Stromal/Stem Cells: A New Treatment for Sepsis and Septic Shock? Stem Cells. 2017 Dec;35(12):2331-2339. doi: 10.1002/stem.2695. Epub 2017 Sep 16. PMID: 28856759.
  193. Cheng Y, Cao X, Qin L. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy for Sepsis. Front Immunol. 2020 Apr 21; 11:647. doi: 10.3389/fimmu.2020.00647. PMID: 32373121; PMCID: PMC7186296.
  194. Daniel M, Bedoui Y, Vagner D, Raffray L, Ah-Pine F, Doray B, Gasque P. Pathophysiology of Sepsis and Genesis of Septic Shock: The Critical Role of Mesenchymal Stem Cells (MSCs). Int J Mol Sci. 2022 Aug 17;23(16):9274. doi: 10.3390/ijms23169274. PMID: 36012544; PMCID: PMC9409099.
  195. Blanco NG, Machado NM, Castro LL, Antunes MA, Takiya CM, Trugilho MRO, Silva LR, Paes Leme AF, Domingues RR, Pauletti BA, Miranda BT, Silva JD, Dos Santos CC, Silva PL, Rocco PRM, Cruz FF. Extracellular Vesicles from Different Sources of Mesenchymal Stromal Cells Have Distinct Effects on Lung and Distal Organs in Experimental Sepsis. Int J Mol Sci. 2023 May 4;24(9):8234. doi: 10.3390/ijms24098234. PMID: 37175936; PMCID: PMC10179270.
  196. Devi A, Pahuja I, Singh SP, Verma A, Bhattacharya D, Bhaskar A, Dwivedi VP, Das G. Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases. Cell Mol Immunol. 2023 Jun;20(6):600-612. doi: 10.1038/s41423-023-01028-7. Epub 2023 May 12. PMID: 37173422; PMCID: PMC10176304.
  197. Jain N, Kalam H, Singh L, Sharma V, Kedia S, Das P, Ahuja V, Kumar D. Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis. Nat Commun. 2020 Jun 16;11(1):3062. doi: 10.1038/s41467-020-16877-3. PMID: 32546788; PMCID: PMC7297998.
  198. Fatima S, Kamble SS, Dwivedi VP, Bhattacharya D, Kumar S, Ranganathan A, Van Kaer L, Mohanty S, Das G. Mycobacterium tuberculosis programs mesenchymal stem cells to establish dormancy and persistence. J Clin Invest. 2020 Feb 3;130(2):655-661. doi: 10.1172/JCI128043. PMID: 31647784; PMCID: PMC6994115.
  199. Singh VK, Mishra A, Bark S, Mani A, Subbian S, Hunter RL, Jagannath C, Khan A. Human mesenchymal stem cell based intracellular dormancy model of Mycobacterium tuberculosis. Microbes Infect. 2020 Oct;22(9):423-431. doi: 10.1016/j.micinf.2020.05.015. Epub 2020 Jun 17. PMID: 32562667; PMCID: PMC8059136.
  200. Zhang X, Xie Q, Ye Z, Li Y, Che Z, Huang M, Zeng J. Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities. Front Immunol. 2021 Jul 22; 12:695278. doi: 10.3389/fimmu.2021.695278. PMID: 34367155; PMCID: PMC8340780.
  201. Khan A, Hunter RL, Jagannath C. Emerging role of mesenchymal stem cells during tuberculosis: The fifth element in cell mediated immunity. Tuberculosis (Edinb). 2016 Dec; 101S:S45-S52. doi: 10.1016/j.tube.2016.09.019. Epub 2016 Sep 28. PMID: 27743705.
  202. Pathak L, Das B. Initiation of Post-Primary Tuberculosis of the Lungs: Exploring the Secret Role of Bone Marrow Derived Stem Cells. Front Immunol. 2021 Jan 21;11: 594572. doi: 10.3389/fimmu.2020.594572. PMID: 33584661; PMCID: PMC7873989.
  203. Raghuvanshi S, Sharma P, Singh S, Van Kaer L, Das G. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21653-8. doi: 10.1073/pnas.1007967107. Epub 2010 Dec 6. PMID: 21135221; PMCID: PMC3003090.
  204. Liu M, Wang Z, Ren S, Zhao H. Exosomes derived from mycobacterium tuberculosis-infected MSCs induce a pro-inflammatory response of macrophages. Aging (Albany NY). 2021 Apr 19;13(8):11595-11609. doi: 10.18632/aging.202854. Epub 2021 Apr 19. PMID: 33872217; PMCID: PMC8109131.
  205. Erokhin VV, Vasil'eva IA, Konopliannikov AG, Chukanov VI, Tsyb AF, Bagdasarian TR, Danilenko AA, Lepekhina LA, Kal'sina SSh, Semenkova IV, Agaeva EV. [Systemic transplantation of autologous mesenchymal stem cells of the bone marrow in the treatment of patients with multidrug-resistant pulmonary tuberculosis]. Probl Tuberk Bolezn Legk. 2008;(10):3-6. Russian. PMID: 19086127.
  206. Skrahin A, Ahmed RK, Ferrara G, Rane L, Poiret T, Isaikina Y, Skrahina A, Zumla A, Maeurer MJ. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. Lancet Respir Med. 2014 Feb;2(2):108-22. doi: 10.1016/S2213-2600(13)70234-0. Epub 2014 Jan 9. PMID: 24503266.
  207. Skrahin AE, Jenkins HE, Hurevich H, Solodovnokova V, Isaikina Y, Klimuk D, Rohava Z, Skrahina A. Potential role of autologous mesenchymal stromal cells in the treatment of multidrug and extensively drug-resistant tuberculosis. Eur Respir J. 2016; 48: PA1919. doi: 10.1183/13993003. congress-2016.PA1919
  208. Wang J, Shi P, Chen D, Wang S, Wang P, Feng X, Zhang L. Research Status of the Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of COVID-19-Related Pneumonia: A Systematic Review and Meta-Analysis. Stem Cells Dev. 2021 Oct 1;30(19):947-969. doi: 10.1089/scd.2021.0179. PMID: 34416823.
  209. Zhang Z, Shao S, Liu X, Tong Z. Effect and safety of mesenchymal stem cells for patients with COVID-19: Systematic review and meta-analysis with trial sequential analysis. J Med Virol. 2023 Apr;95(4):e28702. doi: 10.1002/jmv.28702. PMID: 36964933.
  210. Liu Q, Ma F, Zhong Y, Wang G, Hu L, Zhang Y, Xie J. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: a meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2023 May 4;14(1):118. doi: 10.1186/s13287-023-03286-8. PMID: 37143167; PMCID: PMC10159228.
  211. Taufiq H, Shaik Fakiruddin K, Muzaffar U, Lim MN, Rusli S, Kamaluddin NR, Esa E, Abdullah S. Systematic review and meta-analysis of mesenchymal stromal/stem cells as strategical means for the treatment of COVID-19. Ther Adv Respir Dis. 2023 Jan-Dec; 17:17534666231158276. doi: 10.1177/17534666231158276. PMID: 37128999; PMCID: PMC10140776.
  212. Chen L, Xu Q, Sheng F, Wang B. Efficacy and Safety of Mesenchymal Stem Cells for COVID-19 Infection: A Meta-Analysis and Systematic Review. Discov Med. 2023 Apr 1;35(175):201-207. doi: 10.24976/Discov.Med.202335175.21. PMID: 37105930.
  213. Khandpur S, Gupta S, Gunaabalaji DR. Stem cell therapy in dermatology. Indian J Dermatol Venereol Leprol. 2021 Nov-Dec;87(6):753-767. doi: 10.25259/IJDVL_19_20. PMID: 34245532.
  214. Diotallevi F, Di Vincenzo M, Martina E, Radi G, Lariccia V, Offidani A, Orciani M, Campanati A. Mesenchymal Stem Cells and Psoriasis: Systematic Review. Int J Mol Sci. 2022 Dec 1;23(23):15080. doi: 10.3390/ijms232315080. PMID: 36499401; PMCID: PMC9740222.
  215. Haseqawa T, Ikeda S. Mesenchymal stem cells for the treatment of skin diseases. AIMS Cell Tiss Eng. 2017; 1(2): 104-117. doi:3934/celltissue. 2017.2.104
  216. Damayanti RH, Rusdiana T, Wathoni N. Mesenchymal Stem Cell Secretome for Dermatology Application: A Review. Clin Cosmet Investig Dermatol. 2021 Oct 5;14:1401-1412. doi: 10.2147/CCID.S331044. PMID: 34675575; PMCID: PMC8502696.
  217. Bellei B, Papaccio F, Filoni A, Caputo S, Lopez G, Migliano E, Picardo M. Extracellular fraction of adipose tissue as an innovative regenerative approach for vitiligo treatment. Exp Dermatol. 2019 Jun;28(6):695-703. doi: 10.1111/exd.13954. PMID: 31066942.
  218. Bellei B, Migliano E, Picardo M. Research update of adipose tissue-based therapies in regenerative dermatology. Stem Cell Rev Rep. 2022 Aug;18(6):1956-1973. doi: 10.1007/s12015-022-10328-w. Epub 2022 Mar 1. PMID: 35230644.
  219. Merimi M, Fahmi H, De Kock J, Beguin C, Burny A, Moll G, Poggi A, Najar M. Mesenchymal Stem/Stromal Cells as a Therapeutic Tool in Cell-Based Therapy and Regenerative Medicine: An Introduction Expertise to the Topical Collection. Cells. 2022 Oct 8;11(19):3158. doi: 10.3390/cells11193158. PMID: 36231120; PMCID: PMC9562654.
  220. Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal Stem Cells for Regenerative Medicine. Cells. 2019 Aug 13;8(8):886. doi: 10.3390/cells8080886. PMID: 31412678; PMCID: PMC6721852.
  221. Fitzsimmons REB, Mazurek MS, Soos A, Simmons CA. Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering. Stem Cells Int. 2018 Aug 19;2018:8031718. doi: 10.1155/2018/8031718. PMID: 30210552; PMCID: PMC6120267.
  222. Wei CC, Lin AB, Hung SC. Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry. Cell Transplant. 2014;23(4-5):505-12. doi: 10.3727/096368914X678328. PMID: 24816447.
  223. Portron S, Soueidan A, Marsden AC, Rakic M, Verner C, Weiss P, Badran Z, Struillou X. Periodontal regenerative medicine using mesenchymal stem cells and biomaterials: A systematic review of pre-clinical studies. Dent Mater J. 2019 Dec 1;38(6):867-883. doi: 10.4012/dmj.2018-315. Epub 2019 Sep 11. PMID: 31511473.
  224. Hwang JJ, Rim YA, Nam Y, Ju JH. Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis. Front Immunol. 2021 Mar 8;12:631291. doi: 10.3389/fimmu.2021.631291. PMID: 33763076; PMCID: PMC7982594.
  225. Lv Z, Cai X, Bian Y, Wei Z, Zhu W, Zhao X, Weng X. Advances in Mesenchymal Stem Cell Therapy for Osteoarthritis: From Preclinical and Clinical Perspectives. Bioengineering (Basel). 2023 Feb 2;10(2):195. doi: 10.3390/bioengineering10020195. PMID: 36829689; PMCID: PMC9952673.
  226. Wang Q, Wang Y, Chang C, Ma F, Peng D, Yang S, An Y, Deng Q, Wang Q, Gao F, Wang F, Tang H, Qi X, Jiang X, Cai D, Zhou G. Comparative analysis of mesenchymal stem/stromal cells derived from human induced pluripotent stem cells and the cognate umbilical cord mesenchymal stem/stromal cells. Heliyon. 2023 Jan 4;9(1):e12683. doi: 10.1016/j.heliyon.2022.e12683. PMID: 36647346; PMCID: PMC9840238.
  227. Prakash N, Kim J, Jeon J, Kim S, Arai Y, Bello AB, Park H, Lee SH. Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs). Biomater Res. 2023 Apr 18;27(1):31. doi: 10.1186/s40824-023-00371-0. PMID: 37072836; PMCID: PMC10114339.
  228. Aldoghachi AF, Loh JK, Wang ML, Yang YP, Chien CS, Teh HX, Omar AH, Cheong SK, Yeap SK, Ho WY, Ong AH. Current developments and therapeutic potentials of exosomes from induced pluripotent stem cells-derived mesenchymal stem cells. J Chin Med Assoc. 2023 Apr 1;86(4):356-365. doi: 10.1097/JCMA.0000000000000899. Epub 2023 Feb 10. PMID: 36762931.
  229. Dupuis V, Oltra E. Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells. World J Stem Cells. 2021 Aug 26;13(8):1094-1111. doi: 10.4252/wjsc.v13.i8.1094. PMID: 34567428; PMCID: PMC8422924.
  230. Xu M, Shaw G, Murphy M, Barry F. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells. Stem Cells. 2019 Jun;37(6):754-765. doi: 10.1002/stem.2993. Epub 2019 Mar 6. PMID: 30779868; PMCID: PMC6591688.
  231. Spitzhorn LS, Megges M, Wruck W, Rahman MS, Otte J, Degistirici Ö, Meisel R, Sorg RV, Oreffo ROC, Adjaye J. Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature. Stem Cell Res Ther. 2019 Mar 18;10(1):100. doi: 10.1186/s13287-019-1209-x. PMID: 30885246; PMCID: PMC6423778.
  232. Wruck W, Graffmann N, Spitzhorn LS, Adjaye J. Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Acquire Rejuvenation and Reduced Heterogeneity. Front Cell Dev Biol. 2021 Sep 16;9:717772. doi: 10.3389/fcell.2021.717772. PMID: 34604216; PMCID: PMC8481886.
  233. Zhang J, Chen M, Liao J, Chang C, Liu Y, Padhiar AA, Zhou Y, Zhou G. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Hold Lower Heterogeneity and Great Promise in Biological Research and Clinical Applications. Front Cell Dev Biol. 2021 Sep 30;9:716907. doi: 10.3389/fcell.2021.716907. PMID: 34660579; PMCID: PMC8514743.
  234. Sabapathy V, Kumar S. hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine. J Cell Mol Med. 2016 Aug;20(8):1571-88. doi: 10.1111/jcmm.12839. Epub 2016 Apr 21. PMID: 27097531; PMCID: PMC4956943.
  235. Rajasingh S, Sigamani V, Selvam V, Gurusamy N, Kirankumar S, Vasanthan J, Rajasingh J. Comparative analysis of human induced pluripotent stem cell-derived mesenchymal stem cells and umbilical cord mesenchymal stem cells. J Cell Mol Med. 2021 Sep;25(18):8904-8919. doi: 10.1111/jcmm.16851. Epub 2021 Aug 13. PMID: 34390186; PMCID: PMC8435459.
  236. Kim S, Lee SK, Kim H, Kim TM. Exosomes Secreted from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Accelerate Skin Cell Proliferation. Int J Mol Sci. 2018 Oct 11;19(10):3119. doi: 10.3390/ijms19103119. PMID: 30314356; PMCID: PMC6213597.
  237. Lee HR, Kim S, Shin S, Jeong SY, Lee DW, Lim SU, Kang JY, Son MY, Lee C, Yu KR, Kim M, Oh IH. iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs. Int J Mol Sci. 2023 Jan 3;24(1):881. doi: 10.3390/ijms24010881. PMID: 36614321; PMCID: PMC9821152.
  238. Muthu S, Jeyaraman M, Kotner MB, Jeyaraman N, Rajendran RL, Sharma S, Khanna M, Rajendran SNS, Oh JM, Gangadaran P, Ahn BC. Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)-An Indian Perspective. Bioengineering (Basel). 2022 Mar 7;9(3):111. doi: 10.3390/bioengineering9030111. PMID: 35324800; PMCID: PMC8945480.
  239. Bellino S, La Salvia A, Cometa MF, Botta R. Cell-based medicinal products approved in the European Union: current evidence and perspectives. Front Pharmacol. 2023 Jul 31;14:1200808. doi: 10.3389/fphar.2023.1200808. PMID: 37583902; PMCID: PMC10424920.
  240. Fürst-Ladani S, Bührer A, Fürst W, Schober-Ladani N. Regulatory Aspects for Approval of Advanced Therapy Medicinal Products in the EU. Handb Exp Pharmacol. 2023 Apr 6. doi: 10.1007/164_2023_648. Epub ahead of print. PMID: 37017789.
  241. Escacena N, Quesada-Hernández E, Capilla-Gonzalez V, Soria B, Hmadcha A. Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells. Stem Cells Int. 2015;2015:895714. doi: 10.1155/2015/895714. Epub 2015 Jul 27. PMID: 26273307; PMCID: PMC4530293.
  242. Jossen V, van den Bos C, Eibl R, Eibl D. Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges. Appl Microbiol Biotechnol. 2018 May;102(9):3981-3994. doi: 10.1007/s00253-018-8912-x. Epub 2018 Mar 22. PMID: 29564526; PMCID: PMC5895685.
  243. Teale MA, Schneider S, Eibl D, van den Bos C, Neubauer P, Eibl R. Mesenchymal and induced pluripotent stem cell-based therapeutics: a comparison. Appl Microbiol Biotechnol. 2023 Jul;107(14):4429-4445. doi: 10.1007/s00253-023-12583-4. Epub 2023 May 29. PMID: 37246986; PMCID: PMC10313571.
  244. Mebarki M, Abadie C, Larghero J, Cras A. Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products. Stem Cell Res Ther. 2021 Feb 26;12(1):152. doi: 10.1186/s13287-021-02222-y. PMID: 33637125; PMCID: PMC7907784.
  245. Chinnadurai R, Viswanathan S, Moll G. Editorial: Next generation MSC therapy manufacturing, potency and mechanism of action analysis. Front Immunol. 2023 Apr 21;14:1192636. doi: 10.3389/fimmu.2023.1192636. PMID: 37153609; PMCID: PMC10161792.
  246. Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S; ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016 Sep 24;388(10051):1281-90. doi: 10.1016/S0140-6736(16)31203-X. Epub 2016 Jul 29. PMID: 27477896.
  247. Gupta PK, Dutta S, Kala S, Nekkanti M, Desai SC, Mahapatra SS, Dhar A, Raju R, M R, Behera A, P S, Raviraja NS, Viswanathan P, Chandrashekar M, Thej C, K V P, Abraham J, Boggarapu H, Udaykumar K. Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease. Stem Cells Transl Med. 2021 Dec;10(12):1602-1613. doi: 10.1002/sctm.21-0197. Epub 2021 Sep 13. PMID: 34519179; PMCID: PMC8641082.
  248. Hoogduijn MJ, Lombardo E. Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review. Stem Cells Transl Med. 2019 Nov;8(11):1126-1134. doi: 10.1002/sctm.19-0073. Epub 2019 Jul 7. PMID: 31282113; PMCID: PMC6811696.
  249. Mizukami A, Swiech K. Mesenchymal Stromal Cells: From Discovery to Manufacturing and Commercialization. Stem Cells Int. 2018 Apr 11;2018:4083921. doi: 10.1155/2018/4083921. PMID: 30057622; PMCID: PMC6051015.
  250. Madrigal M, Fernández PL, Lleonart R, Carreño L, Villalobos Gorday KA, Rodríguez E, de Cupeiro K, Restrepo CM, Rao KSJ, Riordan NH. Comparison of Cost and Potency of Human Mesenchymal Stromal Cell Conditioned Medium Derived from 2- and 3-Dimensional Cultures. Bioengineering (Basel). 2023 Aug 4;10(8):930. doi: 10.3390/bioengineering10080930. PMID: 37627815; PMCID: PMC10451979.
  251. Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ; Canadian Critical Care Trials Group. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7(10):e47559. doi: 10.1371/journal.pone.0047559. Epub 2012 Oct 25. PMID: 23133515; PMCID: PMC3485008.
  252. Wang Y, Yi H, Song Y. The safety of MSC therapy over the past 15 years: a meta-analysis. Stem Cell Res Ther. 2021 Oct 18;12(1):545. doi: 10.1186/s13287-021-02609-x. PMID: 34663461; PMCID: PMC8522073.
  253. Li DY, Li RF, Sun DX, Pu DD, Zhang YH. Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies. Stem Cell Res Ther. 2021 Aug 18;12(1):461. doi: 10.1186/s13287-021-02496-2. PMID: 34407861; PMCID: PMC8371890.
  254. Xu P, Yang X. The Efficacy and Safety of Mesenchymal Stem Cell Transplantation for Spinal Cord Injury Patients: A Meta-Analysis and Systematic Review. Cell Transplant. 2019 Jan;28(1):36-46. doi: 10.1177/0963689718808471. Epub 2018 Oct 26. PMID: 30362373; PMCID: PMC6322141.
  255. Yao W, Dong H, Qi J, Zhang Y, Shi L. Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2022 Jul 9;51:101545. doi: 10.1016/j.eclinm.2022.101545. PMID: 35844767; PMCID: PMC9270852.
  256. Qu W, Wang Z, Engelberg-Cook E, Yan D, Siddik AB, Bu G, Allickson JG, Kubrova E, Caplan AI, Hare JM, Ricordi C, Pepine CJ, Kurtzberg J, Pascual JM, Mallea JM, Rodriguez RL, Nayfeh T, Saadi S, Durvasula RV, Richards EM, March K, Sanfilippo FP. Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Stem Cells Transl Med. 2022 Jul 20;11(7):688-703. doi: 10.1093/stcltm/szac032. PMID: 35640138; PMCID: PMC9299515.
  257. Yubo M, Yanyan L, Li L, Tao S, Bo L, Lin C. Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: A meta-analysis. PLoS One. 2017 Apr 27;12(4):e0175449. doi: 10.1371/journal.pone.0175449. PMID: 28448518; PMCID: PMC5407776.
  258. Xie B, Chen S, Xu Y, Han W, Hu R, Chen M, He R, Ding S. Clinical Efficacy and Safety of Human Mesenchymal Stem Cell Therapy for Degenerative Disc Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Stem Cells Int. 2021 Sep 13;2021:9149315. doi: 10.1155/2021/9149315. PMID: 34557231; PMCID: PMC8455197.
  259. Fan M, Huang Y, Chen Z, Xia Y, Chen A, Lu D, Wu Y, Zhang N, Qian J. Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis. Stem Cell Res Ther. 2019 May 31;10(1):150. doi: 10.1186/s13287-019-1258-1. Erratum in: Stem Cell Res Ther. 2019 Jul 15;10(1):206. PMID: 31151406; PMCID: PMC6544951.
  260. Chen X, Wang C, Yin J, Xu J, Wei J, Zhang Y. Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. PLoS One. 2015 Aug 31;10(8):e0136991. doi: 10.1371/journal.pone.0136991. PMID: 26323092; PMCID: PMC4554731.
  261. Kim G, Eom YW, Baik SK, Shin Y, Lim YL, Kim MY, Kwon SO, Chang SJ. Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis. J Korean Med Sci. 2015 Oct;30(10):1405-15. doi: 10.3346/jkms.2015.30.10.1405. Epub 2015 Sep 12. PMID: 26425036; PMCID: PMC4575928.
  262. Liu Y, Dong Y, Wu X, Xu X, Niu J. The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials. Stem Cell Res Ther. 2022 May 16;13(1):204. doi: 10.1186/s13287-022-02882-4. PMID: 35578365; PMCID: PMC9109309.
  263. Long Z, Zhang M, Zhang T, Zeng L, Yang K, Yang T, Yu G, Li J, Wu Y, Chen H. The Effectiveness and Safety of Mesenchymal Stem Cells in the Treatment of Osteoarthritis: A Systematic Review and Meta-analysis of 28 Randomized Controlled Trials. Stem Cells Int. 2022 Oct 12;2022:6151866. doi: 10.1155/2022/6151866. PMID: 36277037; PMCID: PMC9581629.
  264. Cao JX, You J, Wu LH, Luo K, Wang ZX. Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review. World J Clin Cases. 2022 Sep 26;10(27):9714-9726. doi: 10.12998/wjcc.v10.i27.9714. PMID: 36186213; PMCID: PMC9516915.
  265. Luk F, de Witte SF, Bramer WM, Baan CC, Hoogduijn MJ. Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review. Expert Rev Clin Immunol. 2015 May;11(5):617-36. doi: 10.1586/1744666X.2015.1029458. Epub 2015 Mar 27. PMID: 25817052.
  266. Hoque F, Akther S, Islam S. Review on therapeutic efficacy of mesenchymal stem cell (MSC) therapy for treating different disease. Int J Clin Exp Med. 2021, 5(2), 96-100. doi: 10.26855/ijcemr.2021.04.001
  267. Egido-Moreno S, Valls-Roca-Umbert J, Céspedes-Sánchez JM, López-López J, Velasco-Ortega E. Clinical Efficacy of Mesenchymal Stem Cells in Bone Regeneration in Oral Implantology. Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021 Jan 21;18(3):894. doi: 10.3390/ijerph18030894. PMID: 33494139; PMCID: PMC7908266.
  268. Kvistad CE, Kråkenes T, Gjerde C, Mustafa K, Rekand T, Bø L. Safety and Clinical Efficacy of Mesenchymal Stem Cell Treatment in Traumatic Spinal Cord Injury, Multiple Sclerosis and Ischemic Stroke - A Systematic Review and Meta-Analysis. Front Neurol. 2022 May 30;13:891514. doi: 10.3389/fneur.2022.891514. PMID: 35711260; PMCID: PMC9196044.
  269. Ranjbaran H, Mohammadi Jobani B, Amirfakhrian E, Alizadeh-Navaei R. Efficacy of mesenchymal stem cell therapy on glucose levels in type 2 diabetes mellitus: A systematic review and meta-analysis. J Diabetes Investig. 2021 May;12(5):803-810. doi: 10.1111/jdi.13404. Epub 2020 Oct 22. PMID: 32926576; PMCID: PMC8089007.
  270. Farini A, Sitzia C, Erratico S, Meregalli M, Torrente Y. Clinical applications of mesenchymal stem cells in chronic diseases. Stem Cells Int. 2014;2014:306573. doi: 10.1155/2014/306573. Epub 2014 Apr 30. PMID: 24876848; PMCID: PMC4021690.
  271. García-Bernal D, García-Arranz M, Yáñez RM, Hervás-Salcedo R, Cortés A, Fernández-García M, Hernando-Rodríguez M, Quintana-Bustamante Ó, Bueren JA, García-Olmo D, Moraleda JM, Segovia JC, Zapata AG. The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy. Front Cell Dev Biol. 2021 Mar 16;9:650664. doi: 10.3389/fcell.2021.650664. PMID: 33796536; PMCID: PMC8007911.
  272. Eiro N, Fraile M, González-Jubete A, González LO, Vizoso FJ. Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges. Int J Mol Sci. 2022 Aug 10;23(16):8905. doi: 10.3390/ijms23168905. PMID: 36012170; PMCID: PMC9408403.
  273. Mastrolia I, Foppiani EM, Murgia A, Candini O, Samarelli AV, Grisendi G, Veronesi E, Horwitz EM, Dominici M. Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review. Stem Cells Transl Med. 2019 Nov;8(11):1135-1148. doi: 10.1002/sctm.19-0044. Epub 2019 Jul 16. PMID: 31313507; PMCID: PMC6811694.
  274. Sensebé L, Krampera M, Schrezenmeier H, Bourin P, Giordano R. Mesenchymal stem cells for clinical application. Vox Sang. 2010 Feb;98(2):93-107. doi: 10.1111/j.1423-0410.2009.01227.x. Epub 2009 Aug 3. PMID: 19663934.
  275. Baldari S, Di Rocco G, Piccoli M, Pozzobon M, Muraca M, Toietta G. Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies. Int J Mol Sci. 2017 Oct 2;18(10):2087. doi: 10.3390/ijms18102087. PMID: 28974046; PMCID: PMC5666769.
  276. Rady D, Abbass MMS, El-Rashidy AA, El Moshy S, Radwan IA, Dörfer CE, Fawzy El-Sayed KM. Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation. Stem Cells Int. 2020 Aug 11;2020:8837654. doi: 10.1155/2020/8837654. PMID: 33953753; PMCID: PMC8063852.
  277. Gemayel J, Chaker D, El Hachem G, Mhanna M, Salemeh R, Hanna C, Harb F, Ibrahim A, Chebly A, Khalil C. Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications. Clin Transl Oncol. 2023 Jul;25(7):2056-2068. doi: 10.1007/s12094-023-03115-7. Epub 2023 Feb 17. PMID: 36808392.
  278. Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K. Challenges and Controversies in Human Mesenchymal Stem Cell Therapy. Stem Cells Int. 2019 Apr 9;2019:9628536. doi: 10.1155/2019/9628536. PMID: 31093291; PMCID: PMC6481040.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?